Price Increases Help Biogen Lift Revenue - WSJ.com

Links shared publicly online about this topic.

  • 1,893
    total visits

Price Increases Help Biogen Lift Revenue - WSJ.com

online.wsj.com

Biogen boosted revenue 10%, aided greatly by a 22% price increase for multiple sclerosis drug Avonex, its top-selling product.

View full resource at online.wsj.com

Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Drug, Avonex

  • Share

Most Recently Shared on July 16, 2009 at 1:17 pm By:

Advertisement